Koffein Viatris (Caffeine)

Caffeine blocks adenosine receptors A1 and A2A, preventing adenosine from producing its usual calming effect on the brain. This antagonism leads to increased neuronal firing and the release of neurotransmitters such as dopamine and norepinephrine, which promote wakefulness and reduce the perception of fatigue.

The specific dose of Koffein Viatris is determined by the prescribing healthcare professional based on the individual’s age, clinical condition and response. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for caffeine in pregnancy and lactation are limited. Healthcare providers usually advise caution, weighing potential benefits against possible risks to the fetus or infant. Women who are pregnant or breastfeeding should discuss use with their doctor before taking Koffein Viatris.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Caffeine is a naturally occurring stimulant with a well‑characterized safety profile and rapid onset of action. Compared with prescription stimulants such as amphetamines, caffeine generally has milder central effects, a lower risk of dependence, and is available over the counter, making it suitable for short‑term use in fatigue and headache relief.

Koffein Viatris should be stored at room temperature, below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight and excessive heat to maintain potency and stability throughout its shelf life.

Koffein Viatris is taken orally, typically as a tablet or capsule, with or without food as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water; it is not intended for sublingual or chewable use unless specifically formulated for that route.

Serious risks, although rare, include cardiac arrhythmias, seizures, severe hypertension and allergic reactions such as rash or anaphylaxis. Patients with pre‑existing heart conditions, uncontrolled hypertension or a history of seizures should be monitored closely or may need to avoid caffeine altogether.

Individuals with known hypersensitivity to caffeine, uncontrolled hypertension, serious cardiac arrhythmias, severe anxiety disorders, or those who are pregnant or breastfeeding without medical advice should avoid using Koffein Viatris. Additionally, patients taking MAO inhibitors or certain antibiotics should consult their physician before use.